ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag infectious disease immunology clinical trials disease medicine

qPCRDriving Wastewater Surveillance for Infectious Disease
Nathan Ni, PhD | Oct 30, 2023 | 3 min read
Natalie Knox and the Public Health Agency of Canada’s National Microbiology Laboratory are helping establish a national qPCR-driven wastewater surveillance network for SARS-CoV-2 and other diseases.
Infectious Disease
The Scientist Staff | Nov 23, 1997 | 3 min read
Edited by: Steve Bunk J.L. Eron, S.L. Benoit, J. Jemsek, R.D. MacArthur, J. Santana, J.B. Quinn, D.R. Kuritzkes, M.A. Fallon, M. Rubin, "Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter," New England Journal of Medicine, 333:1662-9, 1995. (Cited in 120 publications through October 1997) Comments by Joseph Jemsek, Nalle Clinic, Charlotte, N.C. Among viruses that cause infectious disease, HIV is particularly adept at mutating
Image of various medical supplies on blue background
Relevant Models Reflect Real-world Needs
Deanna MacNeil, PhD | Aug 1, 2023 | 1 min read
Jie Sun shares how his curiosity, creativity, and motivation to address clinical public health needs steer his research in immunology and infectious disease.
DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
Sun
Relevant Models Reflect Real-World Needs
The Scientist | May 30, 2023 | 1 min read
Jie Sun shares how his curiosity, creativity, and motivation to address clinical public health needs steer his research in immunology and infectious disease.
A triangular sign affixed to a tree displaying the silhouette of a tick.
Newly Developed mRNA Vaccine Protects Against Lyme Disease
Charlene Lancaster, PhD | Nov 13, 2023 | 5 min read
Leveraging the same mRNA platform used for COVID-19 vaccines, researchers generated a vaccine that prevents mice from acquiring Lyme disease.
Image of a white cardboard box with a blue vertical stripe on the left side, the word “Apixaban” in blue lettering at the bottom, and a depiction of apixaban’s molecular structure in black.
Blood Thinner Ineffective for COVID-19 Patients: Study
Dan Robitzski | Nov 28, 2022 | 2 min read
A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.
Illustration of woman looking at floating cells through a telescope
Opinion: New Diabetes Drug Signals Shift to Preventing Autoimmunity
Jane Buckner, MD and Carla Greenbaum, MD | Mar 1, 2023 | 4 min read
A therapy for type 1 diabetes is the first to treat patients before symptoms appear, paving the way toward preventing this and other autoimmune diseases.
Stalking Infectious Disease
Eugene Russo | Jun 11, 2000 | 8 min read
Graphic: Cathleen Heard Law enforcement officials routinely use DNA fingerprinting as a tool to get the guilty punished. Defense lawyers often rely on the same tool to free the innocent. Though their labs may be less dramatic settings than criminal courtrooms, life science researchers also use DNA fingerprinting, but rather than capturing criminals, their goal is to keep tabs on a different sort of culprit: infectious disease. The technology has revolutionized the way diseases are tracked and th
Transmission electron microscope image of Zika virus particles
T Cell–Boosting Zika Vaccine Protects Mice from the Virus
Ruth Williams | May 12, 2021 | 4 min read
By avoiding the production of antibodies, something vaccines ordinarily induce, the immunization sidesteps the problem of antibody-dependent enhancement, which can amplify infection by a similar virus and is known to occur with dengue and Zika.

Run a Search

ADVERTISEMENT